Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Actinium Pharmaceuticals Inc
(NY:
ATNM
)
6.940
-0.310 (-4.28%)
Streaming Delayed Price
Updated: 12:05 PM EDT, Apr 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Actinium Pharmaceuticals Inc
< Previous
1
2
Next >
Biotech on a Budget: 7 Stocks Under $10 With Huge Potential
April 15, 2024
With the medical care industry always liable for negative surprises, you might as well go for big upside with under-$10 biotech stocks.
Via
InvestorPlace
High-Risk, High-Reward: Little-Known Biotech Stock ATNM Could Soar on Breakthrough Cancer Treatment
March 15, 2024
ATNM stock offers moonshot or crash-landing possibilities as Actinium Pharmaceuticals works relentlessly to advance life-changing treatments.
Via
InvestorPlace
7 Biotech Penny Stocks on the Verge of Clinical Trial Victory
February 25, 2024
Biotech penny stocks represent one heckuva risk. However, if the stars align, you could be talking some serious money.
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's After-Market Session
February 09, 2024
Via
Benzinga
Actinium Pharma – Pivotal Results From Key New Drug In The Fight Against Cancer
July 14, 2023
Sandesh Seth, CEO & Chairman of the Board of Actinium Pharmaceuticals (NASDAQ: ATNM), was recently a guest on Benzinga’s All-Access.
Via
Benzinga
(ATNM) - Analyzing Actinium Pharmaceuticals's Short Interest
March 09, 2023
Via
Benzinga
Actinium Shares Are Trading Higher After Positive Data From Acute Myeloid Leukemia Trial
October 31, 2022
Via
Benzinga
With Upcoming Pivotal Data, Analyst Sees 145% Upside In Actinium
September 08, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2023
September 06, 2023
Via
Benzinga
Actinium Pharma Cratered 37% Over Two Days — Here's Why, According To CEO Sandesh Seth
February 24, 2023
Actinium CEO Sandesh Seth says the tumble this week had little to do with clinical data.
Via
Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For February 21, 2023
February 21, 2023
Via
Benzinga
What's Going On With Actinium Pharmaceuticals Stock?
February 21, 2023
Actinium Pharmaceuticals Inc (AMEX:ATNM) shares are trading higher Tuesday after the company announced full data results from the pivotal Phase 3 SIERRA trial in patients with active, relapsed or...
Via
Benzinga
Why Owlet Shares Are Trading Higher By Over 45%; Here Are 20 Stocks Moving Premarket
February 21, 2023
Gainers Troika Media Group Inc (NASDAQ: TRKA) shares rose 65.9% to $0.37 in pre-market trading after dropping 4% on Friday.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
February 21, 2023
It's time to start another day of trading with a breakdown of the biggest pre-market stock movers traders need to know about for Tuesday!
Via
InvestorPlace
Dollar Tree, Dycom Industries, Chico's FAS And Other Big Losers From Tuesday
November 23, 2022
U.S. stocks closed higher on Tuesday, with the Dow Jones gaining around 400 points. Here is the list of some big stocks recording losses in the previous session.
Via
Benzinga
Why American Eagle Outfitters Shares Climbed Over 18%; Here Are 78 Biggest Movers From Yesterday
November 23, 2022
Gainers Cosmos Holdings Inc. (NASDAQ: COSM) jumped 86.9% to close at $0.3275 on Tuesday after jumping 21% on Monday. Cosmos Health agreed to sell its Sky Premium Life Luxury food supplement brand on...
Via
Benzinga
Why Dollar Tree Shares Are Trading Lower By 10%? Here Are 53 Stocks Moving In Tuesday's Mid-Day Session
November 22, 2022
Gainers Palisade Bio, Inc. (NASDAQ: PALI) shares jumped 99.1% to $4.42 after the company announced the FDA granted Fast Track designation to LB1148 for the acceleration of time to return of bowel...
Via
Benzinga
4 Analysts Have This to Say About Actinium Pharmaceuticals
October 31, 2022
Over the past 3 months, 4 analysts have published their opinion on Actinium Pharmaceuticals (AMEX:ATNM) stock. These analysts are typically employed by large Wall Street banks and tasked with...
Via
Benzinga
Why Is Getty Images (GETY) Stock Up 33% Today?
October 31, 2022
Getty Images (GETY) stock is rising higher on Monday with heavy trading despite a lack of news concerning the company today.
Via
InvestorPlace
Why Sonnet BioTherapeutics Shares Surged Over 66%; Here Are 63 Biggest Movers From Yesterday
November 01, 2022
Gainers Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) climbed 66.4% to close at $1.93 on Monday after the company announced an agreement with Janssen for the evaluation of three Sonnet product...
Via
Benzinga
PERF Stock Soars 21% on First Trading Day
October 31, 2022
Perfect (PERF) stock is taking off on Monday as investors pump shares higher on their first day of trading after a SPAC merger.
Via
InvestorPlace
Actinium (ATNM) Stock Pops on Positive Trial Results
October 31, 2022
Actinium Pharmaceuticals (ATNM) stock is gaining on Monday after posting positive results from a Phase 3 clinical trial.
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
October 31, 2022
Welcome back and get ready for another week of trading as we break down the biggest pre-market stock movers for Monday morning!
Via
InvestorPlace
Top Cheap Stocks: Trading Opportunities For Next Week
April 24, 2022
A security pattern traces the distinct movements of security prices that, once recognized, help traders to make informed trading decisions. Let's look at some cheap stock opportunities by analyzing...
Via
Talk Markets
Biotech Stocks News: What’s Going on With LIXT, PTE, QLGN and ATNM Stocks Today?
April 12, 2022
Biotech stocks are up today amid an influx of positive news. Here's what investors need to know as these small companies skyrocket.
Via
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For September 8, 2022
September 08, 2022
Via
Benzinga
Benzinga's Daily Brief On Trending Tickers For April 12, 2022: Veru, Kohl's Corporation, BioCardia, And More
April 12, 2022
Benzinga’s “Daily Brief On Trending Tickers” highlights top-searched tickers from around the web and uses the Benzinga Pro platform to highlight recent news...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2022
August 25, 2022
Upgrades
Via
Benzinga
The Daily Biotech Pulse: Aeglea Stock Jumps On Inherited Metabolic Disease Data, Partial Hold Lifted On Gilead's 2 Blood Trials, Early Data From Novartis' KRAS Inhibitor And More
April 12, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Why Actinium Pharmaceuticals Stock Is Surging
April 12, 2022
Actinium Pharmaceuticals Inc (AMEX:ATNM) shares are trading higher Tuesday morning after the company announced it entered into a license and supply agreement with Immedica...
Via
Benzinga
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.